These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18591484)

  • 21. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
    Devilbiss DM; Berridge CW
    Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of the prefrontal cortex during working memory in attention-deficit/hyperactivity disorder.
    Sheridan MA; Hinshaw S; D'Esposito M
    J Am Acad Child Adolesc Psychiatry; 2007 Oct; 46(10):1357-1366. PubMed ID: 17885578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder.
    Wolf RC; Plichta MM; Sambataro F; Fallgatter AJ; Jacob C; Lesch KP; Herrmann MJ; Schönfeldt-Lecuona C; Connemann BJ; Grön G; Vasic N
    Hum Brain Mapp; 2009 Jul; 30(7):2252-66. PubMed ID: 19107748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
    Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
    Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point?
    Liston C; Malter Cohen M; Teslovich T; Levenson D; Casey BJ
    Biol Psychiatry; 2011 Jun; 69(12):1168-77. PubMed ID: 21546000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
    Di Miceli M; Gronier B
    Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
    Hong Q; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
    J Neurol Sci; 2009 Dec; 287(1-2):205-11. PubMed ID: 19709672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.
    Ma CL; Sun X; Luo F; Li BM
    Neurosci Bull; 2015 Apr; 31(2):227-34. PubMed ID: 25822217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.
    Spencer RC; Devilbiss DM; Berridge CW
    Biol Psychiatry; 2015 Jun; 77(11):940-50. PubMed ID: 25499957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
    Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Top down attentional deficits in macaques with lesions of lateral prefrontal cortex.
    Rossi AF; Bichot NP; Desimone R; Ungerleider LG
    J Neurosci; 2007 Oct; 27(42):11306-14. PubMed ID: 17942725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.
    Franowicz JS; Kessler LE; Borja CM; Kobilka BK; Limbird LE; Arnsten AF
    J Neurosci; 2002 Oct; 22(19):8771-7. PubMed ID: 12351753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.